Equol: History, chemistry, and formation

Journal of Nutrition

Volumn 140, Issue 7, 2010, Pages

  Setchell, Kenneth D R ^a   Clerici, Carlo ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EQUOL; ISOFLAVONE; ISOFLAVONE DERIVATIVE;

BACTERIUM CULTURE; DIET SUPPLEMENTATION; DRUG STRUCTURE; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTESTINE FLORA; NONHUMAN; REVIEW; URINARY EXCRETION; ANIMAL; BACTERIUM; BIOTRANSFORMATION; CHEMISTRY; INTESTINE; METABOLISM; MICROBIOLOGY; STEREOISOMERISM;

BACTERIA (MICROORGANISMS); EQUIDAE;

ANIMALS; BACTERIA; BIOTRANSFORMATION; HUMANS; INTESTINES; ISOFLAVONES; STEREOISOMERISM;

EID: 77953751445     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.109.119776     Document Type: Review

References (133)

1. Marrian GF, Haslewood GA. Equol, a new inactive phenol isolated from the ketohydroxyoestrin fraction of mares' urine. Biochem J. 1932;26:1227-32.
2. Marrian GF, Beall D. The constitution of equol. Biochem J. 1935;29:1586-9.
3. Bennetts HW, Underwood EJ, Shier FL. A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Aust J Agric Res. 1946;22:131-8.
4. Lightfoot RJ, Croker KP, Neil HG. Failure of sperm transport in relation to ewe infertility following prolonged grazing on oestrogenic pastures. Aust J Agric Res. 1968;18:755-65.
5. Biggers JD, Curnow DH. Oestrogenic activity of subterranean clover. I. The oestrogenic activity of genistein. Biochem J. 1954;58:278-82.
6. Pope GS. The importance of pasture plant oestrogens in the reproduction and lactation of grazing animals. Dairy Sci Abstr. 1954;16:334-55.
7. Braden A, Hart N, Lamberton J. The estrogenic activity and metabolism of certain isoflavones in sheep. Aust J Agric Res. 1967;18:335-48.
8. Nottle MC. Composition of some urinary calculi of ruminants in Western Australia. Res Vet Sci. 1976;21:309-17.
9. Klyne W, Wright AA. Steroids and other lipids of pregnant cow's urine. J Endocrinol. 1959;18:32-45.
10. Common RH, Ainsworth L. Identification of equol in the urine of the domestic fowl. Biochim Biophys Acta. 1961;53:403-4.
11. Chang HH, Robinson AR, Common RH. Excretion of radioactive diadzein and equol as monosulfates and disulfates in the urine of the laying hen. Can J Biochem. 1975;53:223-30.
12. 14C]formononetin including sulfates in the urine of hens. Can J Biochem. 1977;55:50-5.
13. Saitoh S, Sato T, Harada H, Matsuda T. Biotransformation of soy isoflavone-glycosides in laying hens: intestinal absorption and preferential accumulation into egg yolk of equol, a more estrogenic metabolite of daidzein. Biochim Biophys Acta. 2004;1674:122-30.
14. Saitoh S, Sato T, Harada H, Takita T. Transfer of soy isoflavone into the egg yolk of chickens. Biosci Biotechnol Biochem. 2001;65:2220-5.
15. Molteni A, Brizio-Molteni L, Persky V. In vitro hormonal effects of soybean isoflavones. J Nutr. 1995;125:S751-6.
16. Gu L, House SE, Prior RL, Fang N, Ronis MJ, Clarkson TB, Wilson ME, Badger TM. Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women. J Nutr. 2006;136:1215-21.
17. Adlercreutz H, Musey PI, Fotsis T, Bannwart C,Wahala K, Makela T, Brunow G, Hase T. Identification of lignans and phytoestrogens in urine of chimpanzees. Clin Chim Acta. 1986;158:147-54.
18. Blair RM, Appt SE, Franke AA, Clarkson TB. Treatment with antibiotics reduces plasma equol concentration in cynomolgus monkeys (Macaca fascicularis). J Nutr. 2003;133:2262-7.
19. Juniewicz PE, Pallante MS, Moser A, Ewing LL. Identification of phytoestrogens in the urine of male dogs. J Steroid Biochem. 1988;31:987-94.
20. Brown NM, Setchell KDR. Animal models impacted by phytoestrogens in commercial chow: implications for pathways influenced by hormones. Lab Invest. 2001;81:735-47.
21. Nilsson A. Demethylation of the plant oestrogen biochanin A in the rat. Nature. 1961;192:358.
22. Axelson M, Sjovall J, Gustafsson BE, Setchell KDR. Origin of lignans in mammals and identification of a precursor from plants. Nature. 1982;298:659-60.
23. Lundh T. Metabolism of estrogenic isoflavones in domestic animals. Proc Soc Exp Biol Med. 1995;208:33-9.
24. Setchell KDR, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr. 2002;132:3577-84. (Pubitemid 35435031)
25. Shutt D, Braden A. The significance of equol in relation to the oestrogenic responses in sheep ingesting clover with a high formononetin content. Aust J Agric Res. 1968;19:545-53.
26. Lindsay DR, Kelly RW. The metabolism of phyto-oestrogens in sheep. Aust Vet J. 1970;46:219-22.
27. Shutt DA, Cox RI. Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro. J Endocrinol. 1972;52:299-310.
28. Shutt DA. The effects of plant oestrogens on animal reproduction. Endeavour. 1976;35:110-3.
29. Jensen EV. On the mechanism of estrogen action. Perspect Biol Med. 1962;6:47-59.
30. Axelson M, Setchell KDR. The excretion of lignans in rats: evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett. 1981;123:337-42. (Pubitemid 11148771)
31. Setchell KDR, Lawson AM, Mitchell FL, Adlercreutz H, Kirk DN, Axelson M. Lignans in man and in animal species. Nature. 1980;287:740-2.
32. Setchell KDR, Lawson AM, Conway E, Taylor NF, Kirk DN, Cooley G, Farrant RD, Wynn S, Axelson M. The definitive identification of the lignans trans-2,3-bis(3-hydroxybenzyl)-gamma-butyrolactone and 2,3-bis(3-hydroxybenzyl) butane-1,4-diol in human and animal urine. Biochem J. 1981;197:447-58. (Pubitemid 11013976)
33. Setchell KDR, Lawson AM, Borriello SP, Harkness R, Gordon H, Morgan DM, Kirk DN, Adlercreatz H, Anderson LC, et al. Lignan formation in man: microbial involvement and possible roles in relation to cancer. Lancet. 1981;2:4-7.
34. Axelson M, Setchell KDR. Conjugation of lignans in human urine. FEBS Lett. 1980;122:49-53.
35. Axelson M, Kirk DN, Farrant RD, Cooley G, Lawson AM, Setchell KDR. The identification of the weak oestrogen equol [7-hydroxy-3-(49-hydroxyphenyl) chroman] in human urine. Biochem J. 1982;201:353-7. (Pubitemid 12160165)
36. Setchell KDR, Borriello SP, Hulme P, Kirk DN, Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr. 1984;40:569-78. (Pubitemid 14035518)
37. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosinespecific protein kinases. J Biol Chem. 1987;262:5592-5.
38. Messina M, Watanabe S, Setchell KDR. Report on the 8th International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment. J Nutr. 2009;139:S796-802.
39. Chang HS, Robinson AR, Common RH. Lability of equol to acidic hydrolysis procedures. Anal Biochem. 1975;63:290-2.
40. Setchell KDR, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D, Wolfe BE, Nechemias-Zimmer L, Brown NM, et al. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr. 2005;81:1072-9.
41. Coward L, Barnes N, Setchell KDR, Barnes S. Genistein and daidzein, and their β-glycosides conjugates: anti-tumour isoflavones in soybean foods from American and Asian diets. J Agric Food Chem. 1993;41:1961-7.
42. Lamberton JA, Suares H, Watson KG. Catalytic hydrogenation of isoflavones. The preparation of (±)equol and related isoflavones. Aust J Chem. 1978;31:455-7.
43. Setchell KDR, Zhao X, Jha P, Heubi JE, Brown NM. The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers. Am J Clin Nutr. 2009;90:1029-37.
44. Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem. 2004;12:1559-67.
45. Setchell KDR, Sirokin V, Girindus America Inc., Children's Hospital Medical Center, assignees. Method for enantioselective hydrogenation of chromenes. United States patent US 7528267. 2009 Nov 5.
46. Heemstra JM, Kerrigan SA, Doerge DR, Helferich WG, Boulanger WA. Total synthesis of (S)-equol. Org Lett. 2006;8:5441-3.
47. Wahala K, Hase T, Adlercreutz H. Synthesis and labeling of isoflavone phytoestrogens, including daidzein and genistein. Proc Soc Exp Biol Med. 1995;208:27-32.
48. 13C labelled daidzein and formononetin. Bioorg Med Chem Lett. 1998;8:2569-72.
49. 13C]daidzein. J Med Food. 1999;2:99-102.
50. 13C]- isoflavonoid phytoestrogens. Tetrahedron. 2000;56:455-60.
51. Fortina MG, Ricci G, Foschino R, Picozzi C, Dolci P, Zeppa G, Cocolin L, Manachini PL. Phenotypic typing, technological properties and safety aspects of Lactococcus garvieae strains from dairy environments. J Appl Microbiol. 2007;103:445-53.
52. Yee S, Burdock GA, Kurata Y, Enomoto Y, Narumi K, Hamada S, Itoh T, Shimomura Y, Ueno T. Acute and subchronic toxicity and genotoxicity of SE5-OH, an equol-rich product produced by Lactococcus garvieae. Food Chem Toxicol. 2008;46:2713-20.
53. Rotimi VO, Duerden BI. The development of the bacterial flora in normal neonates. J Med Microbiol. 1981;14:51-62. (Pubitemid 11141879)
54. Setchell KDR, Zimmer-Nechemias L, Cai J, Heubi JE. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet. 1997;350:23-7. (Pubitemid 127675034)
55. Setchell KDR, Zimmer-Nechemias L, Cai J, Heubi JE. Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am J Clin Nutr. 1998;68:S1453-61.
56. Atkinson C, Berman S, Humbert O, Lampe JW. In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production. J Nutr. 2004;134:596-9.
57. Halm BM, Franke AA, Ashburn LA, Hebshi SM, Wilkens LR. Oral antibiotics decrease urinary isoflavonoid excretion in children after soy consumption. Nutr Cancer. 2008;60:14-22.
58. Maruo T, Sakamoto M, Ito C, Toda T, Benno Y. Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella. Int J Syst Evol Microbiol. 2008;58:1221-7.
59. Minamida K, Tanaka M, Abe A, Sone T, Tomita F, Hara H, Asano K. Production of equol from daidzein by gram-positive rod-shaped bacterium isolated from rat intestine. J Biosci Bioeng. 2006;102:247-50.
60. Minamida K, Ota K, Nishimukai M, Tanaka M, Abe A, Sone T, Tomita F, Hara H, Asano K. Asaccharobacter celatus gen. nov., sp. nov., isolated from rat caecum. Int J Syst Evol Microbiol. 2008;58:1238-40.
61. Ueno T, Uchiyama S. Identification of the specific intestinal bacteria capable of metabolising soy isoflavone to equol. Ann Nutr Metab. 2002;45:114.
62. Tsangalis D, Ashton JF, McGill AEJ, Shah NP. Enzymic transformation of isoflavone phytoestrogens in soymilk by β-glucosidase-producing Bifidobacteria. J Food Sci. 2002;67:3104-13. (Pubitemid 35376196)
63. Raimondi S, Roncaglia L, De Lucia M, Amaretti A, Leonardi A, Pagnoni UM, Rossi M. Bioconversion of soy isoflavones daidzin and daidzein by Bifidobacterium strains. Appl Microbiol Biotechnol. 2009;81:943-50.
64. Hur HG, Lay JO Jr, Beger RD, Freeman JP, Rafii F. Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin. Arch Microbiol. 2000;174:422-8.
65. Tamura M, Tsushida T, Shinohara K. Isolation of an isoflavone- metabolizing, Clostridium-like bacterium, strain TM-40, from human faeces. Anaerobe. 2007;13:32-5.
66. Matthies A, Clavel T, Gutschow M, Engst W, Haller D, Blaut M, Braune A. Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine. Appl Environ Microbiol. 2008;74:4847-52.
67. Wang XL, Hur HG, Lee JH, Kim KT, Kim SI. Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium. Appl Environ Microbiol. 2005;71:214-9.
68. Kim M, Kim SI, Han J, Wang XL, Song DG, Kim SU. Stereospecific biotransformation of dihydrodaidzein into (3S)-equol by the human intestinal bacterium Eggerthella strain Julong 732. Appl Environ Microbiol. 2009;75:3062-8.
69. Yokoyama S, Suzuki T. Isolation and characterization of a novel equol-producing bacterium from human feces. Biosci Biotechnol Biochem. 2008;72:2660-6.
70. Decroos K, Vanhemmens S, Cattoir S, Boon N, Verstraete W. Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions. Arch Microbiol. 2005;183:45-55.
71. Yu ZT, Yao W, Zhu WY. Isolation and identification of equolproducing bacterial strains from cultures of pig faeces. FEMS Microbiol Lett. 2008;282:73-80.
72. Wang XL, Kim HJ, Kang SI, Kim SI, Hur HG. Production of phytoestrogen S-equol from daidzein in mixed culture of two anaerobic bacteria. Arch Microbiol. 2007;187:155-60.
73. Ishimi Y, Oka J, Tabata I, Ohtomo T, Ezaki J, Ueno T, Uchiyama S, Toda T, Uehara M, et al. Effects of soybean isoflavones on bone health and its safety in post-menopausal Japanese women. J Clin Biochem Nutr. 2008;43(Suppl 1):48-52.
74. Matthies A, Blaut M, Braune A. Isolation of a human intestinal bacterium capable of daidzein and genistein conversion. Appl Environ Microbiol. 2009;75:1740-4.
75. Jin JS, Kitahara M, Sakamoto M, Hattori M, Benno Y. Slackia equolifaciens sp. nov., a human intestinal bacterium capable of producing equol. Int J Syst Evol Microbiol. Epub 2009 Sep 4.
76. Jin JS, Nishihata T, Kakiuchi N, Hattori M. Biotransformation of C-glucosylisoflavone puerarin to estrogenic (3S)-equol in co-culture of two human intestinal bacteria. Biol Pharm Bull. 2008;31:1621-5.
77. Cayen MN, Carter AL, Common RH. The conversion of genistein to equol in the fowl. Biochim Biophys Acta. 1964;86:56-64.
78. 13C-labeled tracers in premenopausal women. Am J Clin Nutr. 2003;77:411-9.
79. Grant JK. p-Ethylphenylsulphuric acid in goat urine. Biochem J. 1948;43:523-4.
80. Coldham NG, Howells LC, Santi A, Montesissa C, Langlais C, King LJ, Macpherson DD, Sauer MJ. Biotransformation of genistein in the rat: elucidation of metabolite structure by product ion mass fragmentology. J Steroid Biochem Mol Biol. 1999;70:169-84.
81. Setchell KDR, Brown NM, Zimmer-Nechemias L, Brashear WT, Wolfe BE, Kirschner AS, Heubi JE. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr. 2002;76:447-53. (Pubitemid 34804071)
82. Day AJ, DuPont MS, Ridley S, Rhodes M, Rhodes MJ, Morgan MR, Williamson G. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Lett. 1998;436:71-5.
83. Steer TE, Johnson IT, Gee JM, Gibson GR. Metabolism of the soybean isoflavone glycoside genistin in vitro by human gut bacteria and the effect of prebiotics. Br J Nutr. 2003;90:635-42.
84. Bannwart C, Adlercreutz H, Fotsis T, Wahala K, Hase T, Brunow G. Identification of O-desmethylangolensin, a metabolite of daidzein and of matairesinol, one likely plant precursor of the animal lignan enterolactone in human urine. Finn Chem Lett. 1984;120-5.
85. Kelly GE, Joannou GE, Reeder AY, Nelson C, Waring MA. The variable metabolic response to dietary isoflavones in humans. Proc Soc Exp Biol Med. 1995;208:40-3.
86. Ishiwata N, Melby MK, Mizuno S, Watanabe S. New equol supplement for relieving menopausal symptoms: randomized, placebo-controlled trial of Japanese women. Menopause. 2009;16:141-8.
87. Setchell KDR, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr. 1999;129:S758-67.
88. Uehara M, Ohta A, Sakai K, Suzuki K, Watanabe S, Adlercreutz H. Dietary fructooligosaccharides modify intestinal bioavailability of a single dose of genistein and daidzein and affect their urinary excretion and kinetics in blood of rats. J Nutr. 2001;131:787-95.
89. Lampe JW, Skor HE, Li S, Wahala K, Howald WN, Chen C. Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women. J Nutr. 2001;131:740-4. (Pubitemid 32199139)
90. Nettleton JA, Greany KA, Thomas W, Wangen KE, Adlercreutz H, Kurzer MS. Plasma phytoestrogens are not altered by probiotic consumption in postmenopausal women with and without a history of breast cancer. J Nutr. 2004;134:1998-2003. (Pubitemid 39031330)
91. Greany KA, Nettleton JA, Wangen KE, Thomas W, Kurzer MS. Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal women. J Nutr. 2004;134:3277-83. (Pubitemid 39602998)
92. Bonorden MJ, Greany KA, Wangen KE, Phipps WR, Feirtag J, Adlercreutz H, Kurzer MS. Consumption of Lactobacillus acid-ophilus and Bifidobacterium longum do not alter urinary equol excretion and plasma reproductive hormones in premenopausal women. Eur J Clin Nutr. 2004;58:1635-42.
93. Gardana C, Canzi E, Simonetti P. The role of diet in the metabolism of daidzein by human faecal microbiota sampled from Italian volunteers. J Nutr Biochem. 2009;20:940-7.
94. Lampe JW, Karr SC, Hutchins AM, Slavin JL. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med. 1998;217:335-9.
95. Setchell KDR, Cole SJ. Method of defining equol-producer status and its frequency among vegetarians. J Nutr. 2006;136:2188-93.
96. Thigpen JE, Setchell KDR, Ahlmark KB, Locklear J, Spahr T, Caviness GF, Goelz MF, Haseman JK, Newbold RR, et al. Phytoestrogen content of purified, open- and closed-formula laboratory animal diets. Lab Anim Sci. 1999;49:530-6.
97. Thigpen JE, Setchell KDR, Padilla-Banks E, Haseman JK, Saunders HE, Caviness GF, Kissling GE, Grant MG, Forsythe DB. Variations in phytoestrogen content between different mill dates of the same diet produces significant differences in the time of vaginal opening in CD-1 mice and F344 rats but not in CD Sprague-Dawley rats. Environ Health Perspect. 2007;115:1717-26.
98. Thigpen JE, Haseman JK, Saunders HE, Setchell KDR, Grant MG, Forsythe DB. Dietary phytoestrogens accelerate the time of vaginal opening in immature CD-1 mice. Comp Med. 2003;53:607-15.
99. Thigpen JE, Setchell KDR, Saunders HE, Haseman JK, Grant MG, Forsythe DB. Selecting the appropriate rodent diet for endocrine disruptor research and testing studies. ILAR J. 2004;45:401-16.
100. Atkinson C, Frankenfeld CL, Lampe JW. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood). 2005;230:155-70. (Pubitemid 40293689)
101. Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer. 2000;36:27-32. (Pubitemid 30317832)
102. Watanabe S, Yamaguchi M, Sobue T, Takahashi T, Miura T, Arai Y, Mazur W, Wahala K, Adlercreutz H. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr. 1998;128:1710-5. (Pubitemid 28452856)
103. Arai Y, Uehara M, Sato Y, Kimira M, Eboshida A, Adlercreutz H, Watanabe S. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol. 2000;10:127-35.
104. Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T, Fujioka T, Mori M, Kim WJ, et al. Comparisons of percent equol producers between prostate cancer patients and controls: casecontrolled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol. 2004;34:86-9.
105. Song KB, Atkinson C, Frankenfeld CL, Jokela T, Wahala K, Thomas WK, Lampe JW. Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr. 2006;136:1347-51.
106. Lampe JW. Is equol the key to the efficacy of soy foods? Am J Clin Nutr. 2009;89:S1664-7.
107. Niculescu MD, Pop EA, Fischer LM, Zeisel SH. Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not. J Nutr Biochem. 2007;18:380-90.
108. Frankenfeld CL, Atkinson C, Thomas WK, Goode EL, Gonzalez A, Jokela T, Wahala K, Schwartz SM, Li SS, Lampe JW. Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes. Exp Biol Med (Maywood). 2004;229:902-13.
109. Bolca S, Possemiers S, Herregat A, Huybrechts I, Heyerick A, De Vriese S, Verbruggen M, Depypere H, De Keukeleire D, et al. Microbial and dietary factors are associated with the equol producer phenotype in healthy postmenopausal women. J Nutr. 2007;137:2242-6.
110. Nagata C, Ueno T, Uchiyama S, Nagao Y, Yamamoto S, Shibuya C, Kashiki Y, Shimizu H. Dietary and lifestyle correlates of urinary excretion status of equol in Japanese women. Nutr Cancer. 2008;60:49-54.
111. Tamura A, Shiomi T, Hachiya S, Shigematsu N, Hara H. Low activities of intestinal lactase suppress the early phase absorption of soy isoflavones in Japanese adults. Clin Nutr. 2008;27:248-53.
112. Miyanaga N, Akaza H, Takashima N, Nagata Y, Sonoda T, Mori M, Naito S, Hirao Y, Tsukamoto T, et al. Higher consumption of green tea may enhance equol production. Asian Pac J Cancer Prev. 2003;4:297-301.
113. Teas J, Hurley TG, Hebert JR, Franke AA, Sepkovic DW, Kurzer MS. Dietary seaweed modifies estrogen and phytoestrogen metabolism in healthy postmenopausal women. J Nutr. 2009;139:939-44.
114. Vedrine N, Mathey J, Morand C, Brandolini M, Davicco MJ, Guy L, Remesy C, Coxam V, Manach C. One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women. Eur J Clin Nutr. 2006;60:1039-45.
115. Clerici C, Setchell KDR, Battezzati PM, Pirro M, Giuliano V, Asciutti S, Castellani D, Nardi E, Sabatino G, et al. Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. J Nutr. 2007;137:2270-8.
116. Wakai K, Egami I, Kato K, Kawamura T, Tamakoshi A, Lin Y, Nakayama T, Wada M, Ohno Y. Dietary intake and sources of isoflavones among Japanese. Nutr Cancer. 1999;33:139-45.
117. Somekawa Y, Chiguchi M, Ishibashi T, Aso T. Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol. 2001;97:109-15.
118. Izumi T, Piskula MK, Osawa S, Obata A, Tobe K, Saito M, Kataoka S, Kubota Y, Kikuchi M. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J Nutr. 2000;130:1695-9. (Pubitemid 30451055)
119. Setchell KDR, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A, Heubi JE. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr. 2001;131:S1362-75.
120. Zubik L, Meydani M. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am J Clin Nutr. 2003;77:1459-65. (Pubitemid 39655280)
121. Setchell KDR, Zhao X, Shoaf SE, Ragland K. The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women. J Nutr. 2009;139:2037-43.
122. Setchell KDR, Cole SJ. Variations in isoflavone levels in soy foods and soy protein isolates and issues related to isoflavone databases and food labeling. J Agric Food Chem. 2003;51:4146-55.
123. Valentin-Blasini L, Sadowski MA, Walden D, Caltabiano L, Needham LL, Barr DB. Urinary phytoestrogen concentrations in the U.S. population (1999-2000). J Expo Anal Environ Epidemiol. 2005;15:509-23.
124. Peeters PH, Slimani N, van der Schouw YT, Grace PB, Navarro C, Tjonneland A, Olsen A, Clavel-Chapelon F, Touillaud M, et al. Variations in plasma phytoestrogen concentrations in European adults. J Nutr. 2007;137:1294-300.
125. Ward H, Chapelais G, Kuhnle GG, Luben R, Khaw KT, Bingham S. Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study. Breast Cancer Res. 2008;10:R32.
126. Travis RC, Spencer EA, Allen NE, Appleby PN, Roddam AW, Overvad K, Johnsen NF, Olsen A, Kaaks R, et al. Plasma phytooestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer. 2009;100:1817-23.
127. Goodman MT, Shvetsov YB, Wilkens LR, Franke AA, Le Marchand L, Kakazu KK, Nomura AM, Henderson BE, Kolonel LN. Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study. Cancer Prev Res (Phila Pa). 2009;2:887-94.
128. Murphy PA, Barua K, Hauck CC. Solvent extraction selection in the determination of isoflavones in soy foods. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;777:129-38.
129. Atkinson C, Newton KM, Aiello Bowles EJ, Lehman CD, Stanczyk FZ, Westerlind KC, Li L, Lampe JW. Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States. Breast Cancer Res Treat. 2009;116:587-94.
130. Zhao JH, Sun SJ, Arao Y, Oguma E, Yamada K, Horiguchi H, Kayama F. Identification of equol producers in a Japanese population by high-performance liquid chromatography with coulometric array for determining serum isoflavones. Phytomedicine. 2006;13:304-9.
131. King RA, Bursill DB. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr. 1998;67:867-72.
132. Shelnutt SR, Cimino CO, Wiggins PA, Badger TM. Urinary pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein. Cancer Epidemiol Biomarkers Prev. 2000;9:413-9.
133. Bloedon LT, Jeffcoat AR, Lopaczynski W, Schell MJ, Black TM, Dix KJ, Thomas BF, Albright C, Busby MG, et al. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. Am J Clin Nutr. 2002;76:1126-37.